EMBECTA DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Embecta Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EMBC

Rosen Law Firm is notifying Embecta Corp. investors who purchased stock between November 25, 2025 and May 4, 2026 about a securities class action lawsuit. The lawsuit alleges that Embecta made false and misleading statements regarding its fiscal results and guidance, specifically touting its pen needle business as 'incredibly resolute' before missing expectations and cutting 2026 guidance. Investors with losses exceeding $100,000 are encouraged to join the class action before the August 17, 2026 lead plaintiff deadline.

08/01/2026, 10:12 PM • GlobeNewswire

EMBC Alert: Hagens Berman Investigates Alleged Securities Law Violations at Embecta Corp. (NASDAQ: EMBC) Following Pending Class Action Litigation

Hagens Berman is investigating Embecta Corp. for alleged securities law violations, claiming the company misrepresented the stability of its insulin pen needle business. Embecta's stock plummeted 57.8% after revealing significant revenue decline, slashing full-year EPS guidance by 43% and cutting its quarterly dividend by 93%. The class action lawsuit covers the period from November 25, 2025 to May 4, 2026, with a lead plaintiff deadline of August 17, 2026.

07/30/2026, 7:40 PM • GlobeNewswire

EMBC DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Embecta Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EMBC

Rosen Law Firm is reminding Embecta Corp. investors who purchased stock between November 25, 2025 and May 4, 2026 of an August 17, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Embecta made false and misleading statements about its fiscal results and guidance, particularly regarding its pen needle business, which it described as 'incredibly resolute' before missing expectations and cutting 2026 guidance.

07/29/2026, 10:43 PM • GlobeNewswire

EMBC INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Embecta Corp. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm

Shareholder class action lawsuits have been filed against Embecta Corp. and Via Transportation Inc., with allegations of false statements and failure to disclose segment weakness and revenue guidance disruptions. Additionally, Holzer & Holzer, LLC announced an investigation into ADTRAN Holdings Inc. regarding potential federal securities law violations. Investors who suffered losses during the relevant periods are encouraged to contact the law firm.

07/27/2026, 10:58 AM • GlobeNewswire

VIA INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Via Transportation, Inc. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm

Holzer & Holzer, LLC has filed shareholder class action lawsuits against Via Transportation and Embecta Corp., alleging false and misleading statements in their IPO registration statements and securities disclosures. The firm is also investigating ADTRAN Holdings for potential federal securities law violations. Investors who suffered losses are encouraged to contact the firm.

07/27/2026, 10:52 AM • GlobeNewswire

$EMBC Fraud Notification: Embecta Sued for Fraud Over Misrepresentations about its Insulin Pen Issues – Investors Notified to Contact BFA Law

Embecta Corp. faces a securities fraud class action lawsuit after its stock plummeted 57.8% on May 5, 2026, when the company revealed disappointing Q2 results and admitted to significant market softness in insulin pens and pen needles. Investors allege the company misrepresented the strength of its insulin pen portfolio prior to the announcement. The lead plaintiff deadline is August 17, 2026.

07/24/2026, 6:36 AM • GlobeNewswire

embecta to Report Fiscal Third Quarter Financial Results

Embecta Corp. (EMBC) announced it will host a conference call on August 7, 2026, to discuss fiscal third quarter 2026 financial results and provide an operational update. The company also appointed Nimish Muzumdar as Senior Vice President and President of North America, effective June 15, 2026.

07/23/2026, 5:00 PM • GlobeNewswire

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Embecta Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EMBC

Rosen Law Firm is reminding investors who purchased Embecta Corp. common stock between November 25, 2025 and May 4, 2026 of the August 17, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Embecta made false and misleading statements about its fiscal results and guidance, particularly regarding its pen needle business, which it described as 'incredibly resolute' before missing expectations and cutting 2026 guidance.

07/22/2026, 8:13 PM • GlobeNewswire

CALX DEADLINE: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Calix, Inc. Investors to Secure Counsel Before Important July 27 Deadline in Securities Class Action - CALX

Rosen Law Firm is notifying investors in Calix, Inc., Embecta Corp., and Lucid Group, Inc. of upcoming lead plaintiff deadlines in securities class action lawsuits. The lawsuits allege that defendants made false or misleading statements regarding financial performance and business operations during specified class periods.

07/19/2026, 9:55 PM • GlobeNewswire

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Embecta Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EMBC

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary focus is on Embecta Corp., where investors who purchased stock between November 25, 2025 and May 4, 2026 may be entitled to compensation. The lawsuit alleges that Embecta made false statements about its fiscal results and guidance, particularly regarding its pen needle business, which it described as 'incredibly resolute' before missing expectations and cutting 2026 guidance. The lead plaintiff deadline is August 17, 2026. Similar class actions are also mentioned for Calix, Inc. and Lucid Group, Inc.

07/19/2026, 9:50 PM • GlobeNewswire

Embecta Corp. (EMBC) Faces Securities Class Action Over Alleged Concealed Material Risks to Pen Needle Revenue– HBSS

Embecta Corp. (EMBC) faces a securities class action lawsuit for allegedly concealing material risks to its pen needle business. The company provided reassuring guidance in February 2026 but reported a shocking 61% sequential EPS decline in Q2 2026, with pen needle revenues suffering massive declines. Embecta slashed its full-year EPS guidance by 43% and cut its dividend by 93%, triggering significant shareholder losses.

07/15/2026, 6:32 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Embecta Corp. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Embecta Corp. alleging that the company made materially false and misleading statements about its business and guidance during the period from November 25, 2025 to May 4, 2026. The complaint claims Embecta's pen needle business guidance was unattainable, and the company subsequently missed Q2 2026 expectations with a 14% revenue decline and lowered full-year guidance.

07/14/2026, 12:00 PM • GlobeNewswire

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Embecta Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EMBC

Rosen Law Firm is soliciting investors who purchased shares of Embecta Corp., Nano-X Imaging Ltd., and Lucid Group, Inc. during specified periods to join securities class action lawsuits. The lawsuits allege that these companies made false or misleading statements regarding financial guidance and business performance. Investors with losses exceeding $100,000 are encouraged to secure counsel before the August 17, 2026 lead plaintiff deadline.

07/13/2026, 4:48 PM • GlobeNewswire

Deadline Alert: Embecta Corp. (EMBC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Embecta Corp. faces a securities fraud class action lawsuit after revealing a 14% revenue decline due to weakness in pen needle sales and lowering fiscal 2026 guidance on May 5, 2026. The stock plummeted 57.8% to $3.90 per share. Defendants are accused of making materially false statements and failing to disclose material adverse facts about the company's business and prospects during the Class Period (November 25, 2025 - May 4, 2026). The deadline to file a lead plaintiff motion is August 17, 2026.

07/13/2026, 1:33 PM • GlobeNewswire

EMBC SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Embecta Investors of Securities Class Action Lawsuit Deadline on August 17, 2026

A securities class action lawsuit has been filed against Embecta Corp. (NASDAQ: EMBC) alleging that the company made false and misleading statements about its financial guidance. Embecta's stock plummeted 57.8% on May 5, 2026, after the company disclosed a revenue decline of over 14% and cut its fiscal year 2026 guidance, primarily due to weakness in pen needle sales. The deadline to seek lead plaintiff status is August 17, 2026.

07/11/2026, 8:33 AM • GlobeNewswire